TNF and lymphoma: It is important to note that patients with combination therapy (thiopurine plus anti-TNF) seem to have a significant increase in the risk of lymphoma (up to 6-fold compared with nontreated patients and 2.5-fold compared with patients treated with thiopurines or anti-TNF monotherapy).